← Full evidence page

For the cleanest result, disable browser headers and footers.

Dediabetes Evidence Brief

Insulin Therapies for Diabetes: Evidence and Outcomes

Evidence related to insulin therapies in diabetes studies.

Brief accessed
—

Full evidence pagehttps://www.dediabetes.com/evidence/insulin-therapies

Executive Summary

Insulin Therapies evidence appears to center on HbA1c.

Among 37 indexed studies and 4 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Evidence Snapshot

Studies analyzed
37
Evidence relationships
100
Interventions
4
Outcomes
87
Strong evidence signals
7
Mixed evidence areas
3

Key Findings

  1. 01

    Across 8 studies, Insulin therapy shows a moderate positive signal for HbA1c.

  2. 02

    Across 5 studies, Insulin therapy shows a moderate positive signal for Time in range.

  3. 03

    Across 4 studies, Insulin therapy shows a moderate positive signal for Glucose iAUC (OGTT).

  4. 04

    Across 3 studies, Insulin degludec shows a consistent moderate positive signal for HbA1c.

Question Highlights

What outcomes has Insulin Therapies been studied for?

HbA1c, Time in range, and Total daily insulin dose are among the most studied areas in relation to Insulin Therapies.

HbA1c, Time in range, and Total daily insulin dose are among the best-supported options in the available evidence across 37 studies.

The evidence includes both beneficial and harmful or worsening results.

Read the full answer

Do Insulin Therapies lower HbA1c?

Insulin Therapies may lower HbA1c.

Strong evidence is based on 18 supporting studies.

Read the full answer

How does Insulin Therapies compare across studied outcomes?

HbA1c, Time in range, and Total daily insulin dose have available evidence for Insulin Therapies, but the comparison requires review of the underlying studies.

Evidence is available for both Total daily insulin dose and HbA1c; the underlying studies are needed for a direct comparison.

The evidence includes both beneficial and harmful or worsening results.

Read the full answer

Evidence Categories

The evidence is organized by how consistently it supports a conclusion and how much research is available.

Well-Supported Interventions

The strongest and most consistent evidence for improving this outcome.

Evidence is consistently positive across multiple studies.

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

Leading examples

HbA1c · Time in range · Blood glucose

Evidence basis: 13 evidence pairs - 28 studies

Findings Requiring Careful Interpretation

Results that vary across studies or depend on population, study design, duration, or comparator.

Some evidence is positive, but results are not consistent across all studies.

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Leading examples

HbA1c · Time in range · Total daily insulin dose

Evidence basis: 14 evidence pairs - 29 studies

Emerging Areas of Research

Early positive signals that require additional high-quality research.

Early findings are encouraging, but stronger trials are needed.

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Fasting Plasma Glucose (FPG) may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Leading examples

Fasting Plasma Glucose (FPG) · Glucose iAUC (OGTT) · Estimated glomerular filtration rate

Evidence basis: 6 evidence pairs - 12 studies

About this Evidence Brief

This brief summarizes research currently indexed by Dediabetes Evidence Intelligence. It is not a clinical guideline or personalized medical recommendation. Evidence classifications may change as additional studies are indexed.

Suggested citation

—